Chronic graft-versus-host disease (cGVHD) is one of most common, yet severe, consequences of allogeneic hematopoietic stem cell transplantation. Occurring in up to 70% of patients, cGVHD is the leading cause of non-relapse mortality after allogeneic transplantation. Two new agents, belumosudil ...